Revolution Medicines shared a reflective piece on LinkedIn that highlights a pivotal moment in their research journey. Instead of defending a hypothesis that didn’t yield expected results, they chose to ask why and allowed data to guide them. This approach redefined their perspective on science, illustrating that unexpected findings can illuminate new paths rather than signify failures.
For further insights, check out the first chapter of Revolutionary by Nature, featuring Chief Scientific Officer Jan Smith’s thoughts on embracing where science may lead.
Explore more about Revolution Medicines on OncoDaily.
